Phase I/II Study of SAR422459 in Patients With Stargardt’s Macular Degeneration
Learn more about:
Related Clinical Trial
Function and Imaging Assessments for G1961E-associated Stargardt Disease
Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1
Pupil Dynamics and Color Vision for the Detection of Eye Diseases
Learning Study: Improving Vision in Adults With Macular Degeneration
Oral Metformin for Treatment of ABCA4 Retinopathy
Study of STG-001 in Subjects With Stargardt Disease
Efficacy of Acupuncture in Macular Diseases
Rod and Cone Mediated Function in Retinal Disease
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Microcurrent Stimulation to Treat Macular Degeneration
Improving Vision in Adults With Macular Degeneration
Stem Cell Ophthalmology Treatment Study
Stem Cells Therapy in Degenerative Diseases of the Retina
A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt’s Macular Degeneration
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
Safety and Efficacy of Emixustat in Stargardt Disease
Phase I/II Study of SAR422459 in Patients With Stargardt’s Macular Degeneration
Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease